Simultaneous induction of immunogenic cell death and PD-L1 downregulation by bufalin-based nanovaccines for potentiate HCC immunotherapy.

Mater Today Bio · 2025 · PMC12859641 · PMID 41625365

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

extremely significantno p-value reported

∗ p < 0.05 indicates significant statistical differences, and ∗∗ p < 0.01 indicates extremely significant statistical differences. 3.

also in 7,787 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.